Ikena Oncology

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$0
$0
$0
$0
Gross Profit
-92
-219
EBITDA
-12,086
-11,505
-15,048
-15,425
EBIT
-12,175
-11,595
-15,140
-15,644
Net Income
-9,124
-10,234
-13,730
-16,146
Net Change In Cash
0
0
0
0
Free Cash Flow
-6,260
-8,938
-12,502
-18,304
Cash
39,393
45,190
44,268
52,852
Basic Shares
48,258
48,258
48,258
48,258

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$9,160
$15,618
$30,985
Gross Profit
8,140
13,584
-16,123
EBITDA
-58,973
-74,397
-70,153
-33,594
EBIT
-75,417
-72,186
-35,312
Net Income
-49,234
-68,166
-66,626
-34,115
Net Change In Cash
0
9,160
15,618
30,985
Cost of Revenue
-172,298
69,726
Free Cash Flow
-46,004
-80,157
-75,540
-62,012
Cash
39,393
119,894
59,919
232,217
Basic Shares
48,258
41,735
36,188
35,975

Earnings Calls

Quarter EPS
2024-12-31
-$0.18
2024-09-30
-$0.21
2024-06-30
-$0.28
2024-03-31
-$0.33